Balovaptan

Published

dm+d

Unassigned

New Medicines

Autism spectrum disorder (ASD)

Information

New molecular entity
Roche
Roche

Development and Regulatory status

Discontinued
Discontinued
Discontinued
Apr 20Balovaptan removed from Roche pipeline after PIII study was stopped in the first quarter after a pre-planned futility analysis. Development discontinued. [8,9]

Category

Vasopressin 1a (V1a) receptor antagonist
It is estimated that about 1% of adults have ASD. The prevalence in children is also around 1%. ASD is more commonly diagnosed in boys than in girls, with a ratio of approximately 4:1, although this varies across the spectrum of ASD. [1]
Autism spectrum disorder (ASD)
Oral